|
| Characteristics of high-risk patients | Characteristics of low-risk patients |
|
| Any hospitalization | No event |
| 3 or more delays in treatment | Delay beyond cycle 3 |
| Any delay beyond 40 days | |
| Delay after the first treatment | |
| No treatment on day 7 in any of the first 3 cycles | |
| Dose reduction in first 3 cycles | |
|